<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sun, 05 Apr 2026 05:52:33 -0400--><rss version="2.0">
    <channel>
        <title>Dermata Therapeutics, Inc. (DRMA) Press Releases</title>
        <link>https://ir.dermatarx.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/dermatarx/files/theme/images/logo-sm.png</url>
                <title>Dermata Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/98/dermata-receives-notice-of-acceptance-of-australian-patent</link>
                <pubDate>Thu, 02 Apr 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/98/dermata-receives-notice-of-acceptance-of-australian-patent</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/97/dermata-therapeutics-provides-corporate-update-and-reports</link>
                <pubDate>Thu, 26 Mar 26 17:15:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/97/dermata-therapeutics-provides-corporate-update-and-reports</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/96/dermata-announces-appointment-of-kyra-peckaitis-as-vice</link>
                <pubDate>Tue, 10 Mar 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/96/dermata-announces-appointment-of-kyra-peckaitis-as-vice</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Opens a New Chapter with the Release of Tome Skincare]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/95/dermata-opens-a-new-chapter-with-the-release-of-tome</link>
                <pubDate>Thu, 05 Mar 26 09:00:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/95/dermata-opens-a-new-chapter-with-the-release-of-tome</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/94/dermata-receives-notice-of-grant-of-patent-for</link>
                <pubDate>Tue, 20 Jan 26 08:05:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/94/dermata-receives-notice-of-grant-of-patent-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/93/dermata-therapeutics-announces-closing-of-up-to-12-4</link>
                <pubDate>Mon, 29 Dec 25 16:05:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/93/dermata-therapeutics-announces-closing-of-up-to-12-4</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/92/dermata-therapeutics-announces-up-to-12-4-million-private</link>
                <pubDate>Wed, 24 Dec 25 08:00:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/92/dermata-therapeutics-announces-up-to-12-4-million-private</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/91/a-new-realm-of-skincare-is-coming-dermata-teases-new-otc</link>
                <pubDate>Thu, 04 Dec 25 08:00:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/91/a-new-realm-of-skincare-is-coming-dermata-teases-new-otc</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/90/dermata-therapeutics-provides-corporate-update-and-reports</link>
                <pubDate>Fri, 14 Nov 25 16:05:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/90/dermata-therapeutics-provides-corporate-update-and-reports</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dermatarx.com/news-events/press-releases/detail/89/dermata-announces-acceptance-of-patent-application-for</link>
                <pubDate>Thu, 02 Oct 25 08:00:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/news-events/press-releases/detail/89/dermata-announces-acceptance-of-patent-application-for</guid>
                                                                            </item>
            </channel>
</rss>